• No results found

Feedback from the pilot of the questionnaires

A clinic coordinator: ‘I think survey was good asking how useful the NTKPI were and what we used them for also the weakness and how they could improve them’.

Data Integrity/Medicare Claims Coordinator: ‘I have completed the survey today and find no problems with the questions etc’.

Director of Director of Medical Services, Primary Health Care: ‘I have looked at the version for Primary Health Care services. Overall, I think it is a nicely designed survey. There is some useful information at the beginning, and the survey content and length are fine. Some of the

questions ask for comments (e.g., questions 8, 9, 11, 15, 16, 17, 18). It would be a good idea to allow multi-line edit boxes for these questions. There doesn't seem to be a limit to the number of characters when you type into the boxes provided. However, it is difficult to keep track of your answer, as less than 60 characters are visible at a time’.

Another comment: ‘The dedicated CQI/kpi enthusiasts will be more than happy to write in boxes. The less enamored would probably prefer boxes just to tick’.

District Manager: ‘Not too onerous, no, but I'm with X in terms of the tick-a-box format being more attractive to someone with multiple tasks and responsibilities on their mind’.

General Manager: ‘It doesn't look too onerous, but having said that how many staff are likely to complete it????’.

3-144 References

1. National Health and Medical Research Council. Values and Ethics - Guidelines for Ethical Conduct in Aboriginal and Torres Strait Islander Health Research. Canberra: Australian Government; [cited 2016 January]; Available from: https://www.nhmrc.gov.au/guidelines-publications/e52.

2. Northern Territory Aboriginal Health. Northern Territory Aboriginal Health, Key Performance Information System. 2007 [cited 2014 June ]; Available from:

http://www.nt.gov.au/health/ahkpi/.

3. Pam Gollow. Development of a Performance Reporting System for Indigenous Primary Health Care. Casuarina, NT: Cooperative Research Centre for Aboriginal & Tropical Health, 2003.

4. Hoy WE, Kondalsamy-Chennakesavan S, Wang Z, Briganti E, Shaw J, Polkinghorne K, et al. Quantifying the excess risk for proteinuria, hypertension and diabetes in Australian Aborigines: comparison of profiles in three remote communities in the Northern Territory with those in the AusDiab study. Australian and New Zealand journal of public health. 2007;31(2):177-83.

5. Northern Territory Aboriginal Health. Key Performance Indicators (NT AHKPIs), Data Management Policy and Data Receiving, Security and Access Protocol. Version 2.6. 2010.

6. 3d Governance Alliance. Continuous Quality Improvement (CQI). 3d Governance Alliance; 2015 [cited 2016 January]; Available from:

http://www.3dgovernancealliance.com.au/.

7. Clark GB SS, Aziz K, et al. Continuous quality improvement: essential management approaches. Approved guideline GO-22A.: Wayne, Pa: National Committee for Clinical Laboratory Standards; 1999.

8. Graham N. Quality in health care: theory, application and evolution. Gaithersburg: Aspen Publishers; 1995.

9. Patton MQ. Utilization-focused evaluation. London: SAGE Publications Ltd; 2008.

10. Northern Territory Aboriginal Health. NT Aboriginal Health Key Performance Indicators - Definitions. Darwin: Northern Territory Government of Health, 2014. 11. Kelley E, Hurst J. Health Care Quality Indicators Project Conceptual Framework Paper. Organisation for Economic Co-operation and Development: 2006.

12. SurveyMonkey. Create Surveys, Get Answers. SurveyMonkey; 2015 [cited

2015 September]; Available from:

https://www.surveymonkey.com/?ut_source=header.

13. Australian Health Ministers' Advisory Council. Aboriginal and Torres Strait Islander Health Performance Framework 2014 Report. Canberra: AHMAC, 2015. 14. Australian Institute of Health and Welfare. Australia's health system. Canberra: AIHW; 2014 [cited 2015 December 2015]; Available from:

http://www.aihw.gov.au/australias-health/2014/health-system/#t2.

15. Eades S. Maternal and Child Health Care Services: Actions in the Primary Health Care Setting to Improve the Health of Aboriginal and Torres Strait Islander Women of Childbearing Age, Infants and Young Children. Canberra: Australian Department of Health and Ageing, 2004.

3-145

16. Khan KS, Wojdyla D, Say L, Gulmezoglu AM, Van Look PF. WHO analysis of causes of maternal death: a systematic review. Lancet. 2006;367(9516):1066-74. 17. COAG. National Indigenous Reform Agreement (Closing The Gap). Canberra: Council of Australian Governments, 2011.

18. COAG. National Partnership Agreeement on Indigenous Early Child Development. Canberra: Council of Australian Governments, 2009.

19. Arnold JL, de Costa CM, Howat PW. Timing of transfer for pregnant women from Queensland Cape York communities to Cairns for birthing. Med J Aust. 2009;190(10):594-6.

20. de Costa CM, Wenitong M. Could the Baby Bonus be a bonus for babies? Med J Aust. 2009;190(5):242-3.

21. Reibel T, Walker R. Antenatal services for Aboriginal women: the relevance of cultural competence. Qual Prim Care. 2010;18(1):65-74.

22. Rowe RE, Magee H, Quigley MA, Heron P, Askham J, Brocklehurst P. Social and ethnic differences in attendance for antenatal care in England. Public Health. 2008;122(12):1363-72.

23. Zeitlin J, Wildman K, Breart G, Alexander S, Barros H, Blondel B, et al. Selecting an indicator set for monitoring and evaluating perinatal health in Europe: criteria, methods and results from the PERISTAT project. Eur J Obstet Gynecol Reprod Biol. 2003;28(111):S5-S14.

24. EURO-PERISTAT. Better Statistics for Better Health for pregnant women and their babies. 2012 [cited 2015 October]; Available from:

http://www.europeristat.com/our-project/about-euro-peristat.html.

25. Alexander S, Blondel B, Bouvier-Colle MH, Dattani N, Delnord M, Gissler M, et al. Health and Care of Pregnant Women and Babies in Europe in 2010 in EUROPEAN PERINATAL HEALTH REPORT. EURO-PERISTAT, 2010.

26. OECD. Health at a Glance 2011: OECD Indicators OECD Publishing, 2011.

27. Scott J. Chronic disease profiles in one high risk Indigenous community: a comparison of chronic disease profiles after a 10 year follow up and the relationship between birth weight and chronic disease morbidity and mortality: The University of Queensland; 2014.

28. Dusitsin N, Chompootaweep S, Poomsuwan P, Dusitsin K, Sentrakul P, Lumbiganond P. Development and validation of a simple device to estimate birthweight and screen for low birthweight in developing countries. Am J Public Health. 1991;81(9):1201-5.

29. World Health Organization. Global Nutrition Targets 2025: Low birth weight policy brief. Geneva: 2014 Contract No.: WHO/NMH/NHD/14.5.

30. Bellamy C. The state of the world's children. New York: UNICEF, 2005.

31. UNICEF WHO. Low Birth Weight: country, regional and global estimates. New York: UNICEF: 2004.

32. National Health Performance Committee (NHPC). National Report on Health Sector Performance Indicators 2001. Brisbane: Queensland Health, 2002.

33. Burgess M. Immunisation: a public health success: N S W Public Health Bull. 2003 Jan-Feb;14(1-2):1-5.

34. Menzies RI, Singleton RJ. Vaccine preventable diseases and vaccination policy for indigenous populations. Pediatr Clin North Am. 2009;56(6):1263-83.

3-146

35. Australian Institute of Health and Welfare. Australia's health 2014. . Canberra: AIHW, 2014 Contract No.: Cat. no. AUS 178. .

36. Hull BP, McIntyre PB. Timeliness of childhood immunisation in Australia. Vaccine. 2006;24(20):4403-8. Epub 2006/03/30.

37. Menzies R, Turnour C, Chiu C, McIntyre P. Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2003 to 2006. Communicable diseases intelligence quarterly report. 2008;32 Suppl:S2-67. Epub 2008/08/21.

38. O'Grady KA, Krause V, Andrews R. Immunisation coverage in Australian Indigenous children: Time to move the goal posts. Vaccine. 2009;27(2):307-12. Epub 2008/11/04.

39. Abbott P, Menzies R, Davison J, Moore L, Wang H. Improving immunisation timeliness in Aboriginal children through personalised calendars. BMC public health. 2013;13:598. Epub 2013/06/22.

40. Australian Government Department of Health. Immunise Australia Program - About the Program. Canberra: Australian Government Department of Health,; 2015 [cited 2015 09 12 2015]; Available from: Australian Government Department of Health,.

41. Bates AS, Wolinsky FD. Personal, financial, and structural barriers to immunization in socioeconomically disadvantaged urban children. Pediatrics. 1998;101(4 Pt 1):591-6. Epub 1998/04/29.

42. Danis K, Georgakopoulou T, Stavrou T, Laggas D, Panagiotopoulos T. Socioeconomic factors play a more important role in childhood vaccination coverage than parental perceptions: a cross-sectional study in Greece. Vaccine. 2010;28(7):1861-9.

43. Kim SS, Frimpong JA, Rivers PA, Kronenfeld JJ. Effects of Maternal and Provider Characteristics on Up-to-Date Immunization Status of Children Aged 19 to 35 Months. American Journal of Public Health. 2007;97(2):259-66.

44. Samad L, Tate AR, Dezateux C, Peckham C, Butler N, Bedford H. Differences in risk factors for partial and no immunisation in the first year of life: prospective cohort study. BMJ (Clinical research ed). 2006;332(7553):1312-3.

45. Luman ET, Chu SY. When and why children fall behind with vaccinations: missed visits and missed opportunities at milestone ages. American journal of preventive medicine. 2009;36(2):105-11. Epub 2008/12/09.

46. Bond L, Nolan T, Pattison P, Carlin J. Vaccine preventable diseases and immunisations: a qualitative study of mothers' perceptions of severity, susceptibility, benefits and barriers. Australian and New Zealand journal of public health. 1998;22(4):441-6.

47. World Health Organization. State of the world's vaccines and immunization. Third edition. Geneva: WHO,, 2009.

48. World Health Organization. Country Profile Indicators, Interpretation Guide in Nutrition Information System Geneva: WHO, 2010 Contract No.: ISBN 978 92 4 159995 5

49. World Health Organization. Underweight in children. Geneva: WHO; 2015

[cited 2015 October]; Available from:

3-147

50. Northern Territory Government: Department of Health. Growth Assessment and Action (GAA) Program. Darwin: Northern Territory Government of Australia; 2015

[cited 2015 November]; Available from:

http://www.health.nt.gov.au/Womens_Health/Maternal_and_Infant_Health/index.as px.

51. Northern Territory Government: Department of Health. Healthy Under 5 Kids. Darwin: Northern Territory Government of Australia; 2015 [cited 2015 November];

Available from:

http://www.health.nt.gov.au/Child_and_Youth_Health/Healthy_Under_5_Kids/index. aspx.

52. United Nations. Road map towards the implementation of the United Nations Millennium Declaration: Report of the Secretary-General. New York: United Nations, 2001.

53. Central Australian Rural Practitioners Association. A clinical manual for primary health care practitoners in remote and rural communities in Central and Northern Australia. Alice Springs: Central Australian Rural Practitioners Association., 2009. 54. Centres for Disease Control and Prevention. Recommendations to prevent and control iron deficiency in the United States. Morbidity and Mortality Weekly Report. 1998;47((no.RR-3)):1-29.

55. WHO. Iron deficiency anaemia: assessment, prevention, and control. A guide for programme managers. Geneva,: World Health Organization, 2001.

56. WHO and UNICEF. Joint statement by the World Health Organisation and the United Nations Children Fund. Focusing on anaemia - torwards an integrated approach for effective anaemia control. 2014.

57. Algarin C, Nelson CA, Peirano P, Westerlund A, Reyes S, Lozoff B. Iron- deficiency anemia in infancy and poorer cognitive inhibitory control at age 10 years. Dev Med Child Neurol. 2013;55(5):453-8.

58. Horton S RJ. The economics of iron deficiency. Food Policy. 2003;28(1):51-75. 59. Shapiro MJ, Gettinger A, Corwin HL, Napolitano L, Levy M, Abraham E, et al. Anemia and blood transfusion in trauma patients admitted to the intensive care unit. J Trauma. 2003;55(2):269-73.

60. WHO. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. Vitamin and Mineral Nutrition Information system. Geneva: World Health Organisation; 2011 [cited 2015 05/01/2015]; Available from:

http://www.who.int/vmnis/indicators/haemoglobin.pdf.

61. Karen Edmund, Barbara Paterson, White A. Anaemia in Children. 2002.

62. Kruske SG, Ruben AR, Brewster DR. An iron treatment trial in an aboriginal community: improving non-adherence. J Paediatr Child Health. 1999;35(2):153-8. 63. Mills AF & Meadows N. Screening for anaemia: evaluation of a haemoglobinometer. Arch Dis Child. 1989;64(10):1468-71.

64. USAID. Anemia Detection in Health Services: Guidelines for Program Managers. Washington, USA: Program for Appropriate Technology in Health (PATH), U.S Agency for International Development, 1996.

65. Gwetu TP, Chhagan MK, Craib M, Kauchali S. Hemocue Validation for the diagnosis of Anaemia in Children: A Semi-Systematic Review. Pediat Therapeut. 2013;4(1).

3-148

66. Sanchis-Gomar F, Cortell-Ballester J, Pareja-Galeano H, Banfi G, Lippi G. Hemoglobin point-of-care testing: the HemoCue system. J Lab Autom. 2013;18(3):198-205.

67. Central Australian Aboriginal Congress Incorporated, editor. Anaemia in children in Reference Book for the Remote Primary Health Care Manuals. Alice Springs: Centre for Remote Health; 2014.

68. Domellof M, Dewey KG, Lonnerdal B, Cohen RJ, Hernell O. The diagnostic criteria for iron deficiency in infants should be reevaluated. J Nutr. 2002;132(12):3680-6.

69. Emond AM, Hawkins N, Pennock C, Golding J. Haemoglobin and ferritin concentrations in infants at 8 months of age. Archives of Disease in Childhood. 1996;74(1):36-9.

70. Vos T, Barker B, Begg S, Stanley L, Lopez AD. Burden of disease and injury in Aboriginal and Torres Strait Islander Peoples: the Indigenous health gap. Int J Epidemiol. 2009;38(2):470-7.

71. Australian Institute of Health and Welfare. The health and welfare of Australia’s Aboriginal and Torres Strait Islander peoples: 2015. . Canberra: AIHW, 2015 Contract No.: Cat. no. IHW 147.

72. Australian Institute of Health and Welfare. Trends in coronary heart disease mortality: age groups and populations. . Canberra: AIHW, 2014.

73. ABS. Australian Aboriginal and Torres Strait Islander Health Survey: first results, Australia, 2012–13. Canberra: ABS, 2013 Contract No.: ABS cat. no. 4727.0.55.001.

74. NHMRC. Strengthening Cardiac Rehabilitation and Secondary Prevention for Aboriginal and Torres Strait Islander Peoples: A Guide for Health Professionals. NHMRC: Canberra, 2005.

75. Bailie RS, Si D, Robinson GW, Togni SJ, D'Abbs PH. A multifaceted health- service intervention in remote Aboriginal communities: 3-year follow-up of the impact on diabetes care. Med J Aust. 2004;181(4):195-200.

76. Wagner EH, Austin BT, Davis C, Hindmarsh M, Schaefer J, Bonomi A. Improving chronic illness care: translating evidence into action. Health Aff. 2001;20(6):64-78. 77. Bailie R, Si D, Dowden M, Lonergan K. Audit and Best Practice for Chronic Disease Project: Final Report. Darwin: Menzies School of Health Research, 2007. 78. Hoy W, Kelly A, Jacups S, McKendry K, Baker P, MacDonald S, et al. Stemming the tide: reducing cardiovascular disease and renal failure in Australian Aborigines. Aust N Z J Med. 1999;29(3):480-3.

79. Hoy WE, Baker PR, Kelly AM, Wang Z. Reducing premature death and renal failure in Australian aboriginals. A community-based cardiovascular and renal protective program. Med J Aust. 2000;172(10):473-8.

80. McDermott R, Tulip F, Schmidt B, Sinha A. Sustaining better diabetes care in remote indigenous Australian communities. BMJ (Clinical research ed). 2003;327(7412):428-30.

81. Rowley KG, Gault A, McDermott R, Knight S, McLeay T, O'Dea K. Reduced prevalence of impaired glucose tolerance and no change in prevalence of diabetes despite increasing BMI among Aboriginal people from a group of remote homeland communities. Diabetes Care. 2000;23(7):898-904.

3-149 NSW: Baker IDI,, 2012.

83. Siitonen OI, Niskanen LK, Laakso M, Siitonen JT, Pyorala K. Lower-extremity amputations in diabetic and nondiabetic patients. A population-based study in eastern Finland. Diabetes Care. 1993;16(1):16-20.

84. ANZDATA. 1980-2009 Australia & New Zealand Dialysis & Transport Registry Annual Reports [Online]. Adelaide: ANZDATA, 2012.

85. Tapp RJ, Shaw JE, Harper CA, de Courten MP, Balkau B, McCarty DJ, et al. The prevalence of and factors associated with diabetic retinopathy in the Australian population. Diabetes Care. 2003;26(6):1731-7.

86. Grace BS, Clayton P, McDonald SP. Increases in renal replacement therapy in Australia and New Zealand: understanding trends in diabetic nephropathy. Nephrology. 2012;17(1):76-84.

87. Erny-Albrecht BP, Oliver-Baxter J,. The role of primary care in primary and secondary prevention of diabetes and related complications. PHCRIS Policy Issue Review. Adelaide: Primary Health Care Research & Information Service,, 2015.

88. Saudek CD, Brick JC. The Clinical Use of Hemoglobin A1c. Journal of diabetes science and technology (Online). 2009;3(4):629-34.

89. WHO. Use of Glycated Haemoglobin (HbA1c) in the Diagnosis of Diabetes Mellitus. Abbreviated Report of a WHO Consultation Geneva: WHO, 2011.

90. Australian Bureau of Statistics. Australian Aboriginal and Torres Strait Islander health survey: updated results, 2012-13 - Australia: Diabetes. Canberra: ABS; 2014 [cited 2016 January].

91. King P, Peacock I, Donnelly R. The UK Prospective Diabetes Study (UKPDS): clinical and therapeutic implications for type 2 diabetes. British Journal of Clinical Pharmacology. 1999;48(5):643-8.

92. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998;352(9131):837-53.

93. Heller SR, on behalf of the ACG. A Summary of the ADVANCE Trial. Diabetes Care. 2009;32(Suppl 2):S357-S61.

94. Colagiuri S DS, Girgis S, Colagiuri R,. National Evidence Based Guideline for Blood Glucose Control in Type 2 Diabetes. Canberra: Diabetes Australia and NHMRC, 2009.

95. Australian Bureau of Statistics. Chronic Kidney Disease. Canberra: ABS; 2014

[cited 2016 January]; Available from:

http://www.abs.gov.au/ausstats/abs@.nsf/Lookup/by%20Subject/4727.0.55.003~201

2-13~Main%20Features~Chronic%20Kidney%20Disease~113.

96. Hoy WE, Mathews JD, McCredie DA, Pugsley DJ, Hayhurst BG, Rees M, et al. The multidimensional nature of renal disease: rates and associations of albuminuria in an Australian Aboriginal community. Kidney Int. 1998;54(4):1296-304.

97. Zeitz C. Indigenous vascular health-bridging the survival gap: strategies for community-based services: Heart Lung Circ. 2009 Apr;18(2):94-5. doi: 10.1016/j.hlc.2009.01.004. Epub 2009 Feb 27.

98. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ (Clinical research ed). 1998;317(7160):703-13.

3-150

99. Britt E, Miller G, Pan CJ, Henderson J, Bayram C, O'Halloran J, et al. General practice activity in Australia 2005-2006. Canberra: AIHW, 2007 Contract No.: AIHW Cat No, GEP 19.

100. Mathers C, Vos T, Stevenson C. The burden of disease and injury in Australia. Canberra: 1999 Contract No.: AIHW Cat No PHE 17.

101. Australian Institute of Health and Welfare. Public health expenditure in Australia, 2007–08. Canberra: AIHW, 2009.

102. Australian Government Department of Health. Medicare Health Assessment for Aboriginal and Torres Strait Islander People (MBS ITEM 715). Canberra: Australian Government,; 2014 [cited 2015 December]; Available from: http://www.health.gov.au/internet/main/publishing.nsf/content/mbsprimarycare_AT

SI_MBSitem715.

103. Harris M. The role of primary health care in preventing theb onset of chronic disease, with a particular focus on the lifestyle risk factors of obesity, tobacco and alcohol. Sydney: Centre for Primary Health Care and Equity, UNSW 2008.

104. Australian Institute of Health and Welfare. Cervical screening in Australia 2012–2013. Canberra: AIHW, 2005 Contract No.: Cat. no. CAN 91.

105. Koefler S. Is cancer a death sentence for Indigenous Australians? The impact of culture on cancer outcomes. Australian Medical Student Journal. 2012;3(1).

106. The Australian Government Department of Health. National Cervical Screening Program. Canberra: The Australian Government Department of Health,; 2013 [updated 05 November 2013; cited 2015 05 12 2015]; Available from: http://www.cancerscreening.gov.au/internet/screening/publishing.nsf/Content/about

-the-programme-2.

107. Mitchell HS. How much cervical cancer is being prevented? . Medical Journal of Australia 2003;178(298).

108. Canfell K, Sitas F, Beral V. Cervical cancer in Australia and the United Kingdom: comparison of screening policy and uptake, and cancer incidence and mortality. Med J Aust. 2006;185(9):482-6. Epub 2006/12/02.

109. Luke C, Nguyen AM, Heard A, Kenny B, Shorne L, Roder D. Benchmarking epidemiological characteristics of cervical cancer in advance of change in screening practice and commencement of vaccination. Australian and New Zealand journal of public health. 2007;31(2):149-54. Epub 2007/04/28.

110. Kirk M HE, Dunne A and Manderson L,. Barriers to and Appropriate Delivery Systems for Cervical Cancer Screening in Aboriginal and Torres Strait Islander Communities In Queensland. Herston: Australian Centre for International & Tropical Health & Nutrition, 1999 Contract No.: ISBN 0-7242-8043-X.

111. Reath J, Carey M. Breast and cervical cancer in indigenous women-overcoming barriers to early detection. Australian family physician. 2008;37(3):178-82. Epub 2008/03/18.

112. Stumpers S and Thomson N. Review of cancer among Indigenous peoples. Australian Indigenous HealthInfoNet, 2009

113. IARC (International Agency for Research on Cancer). Prevention: Cervix cancer screening. . Lyon, France: IARCPress; 2005.

114. Khalbuss WE, Pantanowitz L, Monaco SE. Cytomorphology of unusual primary tumors in the Pap test. CytoJournal. 2013;10:17.

3-151

115. WHO. Comprehensive cervical cancer control: a guide to essential best practice. Geneva: WHO, 2014.

116. Moyer VA. Screening for cervical cancer: U.S. Preventive Services Task Force recommendation statement. Annals of internal medicine. 2012;156(12):880-91, W312. Epub 2012/06/20.

117. Sasieni P, Castanon A, Cuzick J. Effectiveness of cervical screening with age: population based case-control study of prospectively recorded data. BMJ (Clinical research ed). 2009;339:b2968. Epub 2009/07/30.

118. Sawaya GF, McConnell KJ, Kulasingam SL, Lawson HW, Kerlikowske K, Melnikow J, et al. Risk of cervical cancer associated with extending the interval between cervical-cancer screenings. N Engl J Med. 2003;349(16):1501-9. Epub 2003/10/17.

119. Australian Bureau of Statistics. Australian Aboriginal and Torres Strait Islander Health Survey: First Results, Australia, 2012-13. Canberra: Australian Bureau of Statistics, 2013 Contract No.: Report No: 4727.0.55.001.

120. Lawlor DA, Smith GD. Early life determinants of adult blood pressure. Curr Opin Nephrol Hypertens. 2005;14(3):259-64.

121. Australian Institute of Health and Welfare. Australia's health 2010. Canberra: AIHW, 2010 Contract No.: Cat. no. AUS 122.

122. Nascimento LR, Coelli AP, Cade NV, Mill JG, Molina Mdel C. Sensitivity and specificity in the diagnosis of hypertension with different methods. Rev Saude Publica. 2011;45(5):837-44.

123. O'Brien E, Petrie J, Littler W, de Swiet M, Padfield PL, O'Malley K, et al. The British Hypertension Society protocol for the evaluation of automated and semi- automated blood pressure measuring devices with special reference to ambulatory systems. J Hypertens. 1990;8(7):607-19.

124. Carapetis JR, McDonald M, Wilson NJ. Acute rheumatic fever. Lancet. 2005;366(9480):155-68.

125. Carapetis JR, Wolff DR, Currie BJ. Acute rheumatic fever and rheumatic heart disease in the top end of Australia's Northern Territory. Med J Aust. 1996;164(3):146- 9.

126. Tibazarwa KB, Volmink JA, Mayosi BM. Incidence of acute rheumatic fever in the world: a systematic review of population-based studies. Heart. 2008;94(12):1534- 40.

127. Parnaby MG, Carapetis JR. Rheumatic fever in indigenous Australian children. J Paediatr Child Health. 2010;46(9):527-33. Epub 2010/09/22.

128. Australian Institute of Health and Welfare. Rheumatic heart disease and acute rheumatic fever in Australia: 1996 - 2012. Canberra: AIHW, 2013 Contract No.: no. CVD 60.

129. Colquhoun SM, Condon JR, Steer AC, Li SQ, Guthridge S, Carapetis JR. Disparity in Mortality From Rheumatic Heart Disease in Indigenous Australians. J Am Heart Assoc. 2015;4(7):001282.

130. RHDAustralia (ARF/RHD writing group). Australian guideline for prevention, diagnosis and management of acute rheumatic fever and rheumatic heart disease. National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand. , 2012.

3-152

131. Brown A, McDonald MI, Calma T. Rheumatic fever and social justice: Med J Aust. 2007 Jun 4;186(11):557-8.; 2007.

132. Smith MT, Lester-Smith D, Zurynski Y, Noonan S, Carapetis JR, Elliott EJ. Persistence of acute rheumatic fever in a tertiary children's hospital. J Paediatr Child Health. 2011;47(4):198-203. Epub 2011/01/05.

133. Colquhoun SM, Carapetis JR, Kado JH, Steer AC. Rheumatic heart disease and

Related documents